Skip to main content

Table 3 NAT2 genotype frequency.

From: Characterization of N-acetyltransferase 1 and 2 polymorphisms and haplotype analysis for inflammatory bowel disease and sporadic colorectal carcinoma

NAT2Genotype Sporadic-CRC IBD benign IBD dysplasia/cancer Controls Phenotype
  No. % No. % No. % No. %  
NAT2*5B/*6A 26 21.3 85 23.22 5 33.33 54 24.3 Slow
NAT2*4/*5B 22 18 72 19.67 1 6.66 39 17.5 Intermediate
NAT2*5B/*5B 17 13.9 54 14.75 3 20 32 14.4 Slow
NAT2*4/*6A 24 19.7 48 13.11 4 26.66 30 13.5 Intermediate
NAT2*6A/*6A 16 13.2 20 5.46    21 9.45 Slow
NAT2*4/*4 3 2.45 26 7.1    16 7.2 Rapid
NAT2*6A/*7B 3 2.45 6 1.63    3 1.36 Slow
NAT2*5B/*7B 2 1.63 8 2.18    5 2.25 Slow
NAT2*5B/*5C 2 1.63 2 0.54    4 1.8 Slow
NAT2*5A/*6A 0 0 2 0.54    2 0.9 Slow
NAT2*5B/*13 0 0 5 1.36 1 6.66 2 0.9 Intermediate
NAT2*4/*5A 0 0 5 1.36    2 0.9 Intermediate
NAT2*4/*7B 2 1.63 5 1.36 1 6.66 2 0.9 Intermediate
NAT2*5C/*6A 0 0 3 0.819    2 0.9 Slow
NAT2*5A/*5B 1 0.81 8 2.18    1 0.45 Slow
NAT2*5A/*5C 0 0 2 0.54    1 0.45 Slow
NAT2*5B/*12A 1 0.81 0 0    1 0.45 Intermediate
NAT2*5C/*5C 0 0 1 0.27    1 0.45 Slow
NAT2*4/*12A 0 0 0 0    1 0.45 Rapid
NAT2*4/*5C 1 0.81 7 1.91    1 0.45 Intermediate
NAT2*6A/*12A 0 0 0 0    1 0.45 Intermediate
NAT2*6A/*13 1 0.81 1 0.27    1 0.45 Intermediate
NAT2*4/*13 0 0 2 0.54    0 0 Rapid
NAT2*5A/*13 0 0 1 0.27    0 0 Intermediate
NAT2*5A/*5A 1 0.81 1 0.27    0 0 Slow
NAT2*5C/*7B 0 0 2 0.54    0 0 Slow
Total 122   366   15   222   
  1. Genotypes listed by order of decreasing frequency in control group
  2. IBD: inflammatory bowel disease
  3. CRC: colorectal cancer